Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis
- 1 May 1998
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 27 (5) , 197-201
Abstract
In the present study, we examined the expression of CD44 variant exons in human oral squamous cell carcinoma (OSCC). Of ten cell lines from OSCCs, two (KB and H357), as well as the HeLa cell line, failed to express CD44 variant exons. In surgical specimens, all normal mucosa expressed CD44v9 (both mRNA and protein). Of 40 primary OSCCs, 19 (47.5%) showed downregulation of CD44v9, which correlated with tumor cell differentiation, primary metastasis to lymph nodes and secondary metastasis to lymph nodes. The results suggest that the downregulation of CD44v9 may play a role in lymphatic metastasis of OSCC and changes in its expression may be a useful diagnostic tool to determine the metastatic potential of OSCC to lymph nodes. Moreover, three cell lines that failed to express CD44 variant exons might become a useful experimental model to study the role of variant exons in the progression of OSCC.Keywords
This publication has 25 references indexed in Scilit:
- Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunitiesThe Journal of Pathology, 1995
- CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.Journal of Cell Biology, 1995
- Expression of CD44 abnormal transcripts in human gastric carcinomasCancer Letters, 1994
- CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagenSurgical Oncology, 1993
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.Journal of Experimental Medicine, 1993
- A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.Journal of Cell Biology, 1993
- The Core Protein of Epican, a Heparan Sulfate Proteoglycan on Keratinocytes, Is an Alternative Form of CD44Journal of Investigative Dermatology, 1992
- Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.Journal of Cell Biology, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- The behaviour of human oral squamous cell carcinoma in cell cultureThe Journal of Pathology, 1990